| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |